Rituximab therapy in a patient with low grade B-cell lymphoproliferative disease and concomitant acquired angioedema

Ravdeep KaurWake Forest University School of Medicine, Wake Forest University, Winston-Salem, NC, USA

Aerik Anthony WilliamsWake Forest University School of Medicine, Wake Forest University, Winston-Salem, NC, USACorrespondence[email protected]

Catherine Baker SwiftWake Forest University School of Medicine, Wake Forest University, Winston-Salem, NC, USA

Jason W CaldwellWake Forest University School of Medicine, Wake Forest University, Winston-Salem, NC, USA

References

CicardiMZingaleLCPappalardoEFolcioniAAgnostoniAAutoantibodies and lymphoproliferative diseases in acquired C1-inhibitor deficienciesMedicine (Baltimore)200382427428112861105
PubMed Web of Science ®Google Scholar
BranellecABouilletLJavaudNAcquired C1-inhibitor deficiency: 7 patients treated with rituximabJ Clin Immunol201232593694122526593
PubMed Web of Science ®Google Scholar
LeviMHackCEvan OersMHRituximab-induced elimination of acquired angioedema due to C1-inhibitor deficiencyAm J Med20061198e3e516887400
PubMed Web of Science ®Google Scholar
JacksonJSimRBWhaleyKFeigheryCAutoantibody facilitated cleavage of C1-inhibitor in autoimmune angioedemaJ Clin Invest19898326987072536404
PubMed Web of Science ®Google Scholar
AgostoniACicardiMHereditary and acquired C1-inhibitor deficiency: biological and clinical characteristics in 235 patientsMedicine (Baltimore)19927142062151518394
PubMed Web of Science ®Google Scholar
ShoemakerLRSchurmanSJDonaldsonVHDavisAE3rdHereditary angioneurotic oedema: characterization of plasma kinin and vascular permeability-enhancing activitiesClin Exp Immunol199495122288287604
PubMed Web of Science ®Google Scholar